Dr. Arcy Billoria, Head Lab & HIC, Consultant Microbiologist, Infection Control Specialist, Aster Prime Hospital Antimicrobial Resistance (AMR) is when microorganisms develop the ability to grow, even when they are exposed to antimicrobial medicines that are meant to kill them or limit their growth. The World AMR
- Blockage in a major brain blood vessel of a 60-year-old man - Mechanical thrombectomy performed by KIMS Icon Hospital doctors - Procedure completed in record time Doctors at KIMS Icon Hospital, Visakhapatnam, set a remarkable record by successfully treating a stroke patient in just 9 minutes. The
The OSSI survey revealed that 87.2% of surgeons saw higher patient interest after the 2019 IRDAI mandate for inclusion of bariatric and metabolic surgery. However, most surgeons reported under-utilization of insurance coverage due to low awareness, high out of pocket costs, and complex paperwork. A
Aster Whitefield implemented the state-of-the-art technology for cancer treatment last year and is India’s only hospital offering IOeRT, completing 140+ procedures with proven clinical success in a year. Radiation delivered during surgery ensures higher precision, faster recovery, and minimal damage to healthy tissue. Clinical
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda Eli Lilly and Company today announced plans to invest more than $1 Billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative
Second quarter revenue from operations grows 4% sequentially and 2% year-on-year to Rs. 911 Cr 1st half revenue from operations up 6% Syngene International Limited today announced financial results for the second quarter and half year of FY26. Quarterly Financial Highlights (All numbers are in Indian Rupees in Cr except margins) Q2 FY25 Q2 FY26 YoY Change (%) Revenue from Operations 891 911 2% Reported Revenue 908 926 2% Reported EBITDA 261 215 -18% Reported EBITDA margin (%) 28.8% 23.2% Reported PAT (before exceptional items) 106 67 -37% Reported PAT Margin (%) 11.7% 7.3% H1 FY26 Financial Highlights (All numbers are in Indian rupees in Crores except margins) H1 FY25 H1 FY26 YoY Change (%) Revenue from Operations 1,681 1,785 6% Reported Revenue 1,715 1,818 6% Reported EBITDA 449 439 -2% Reported EBITDA margin (%) 26.2% 24.1% Reported PAT (before exceptional items) 161* 154 -4% Reported PAT Margin (%) 9.4% 8.5% Excludes exceptional item of Rs. 21 crores (net of tax) in Q1 FY25 relating to final settlement from an insurance claim. Commenting on the results, Peter Bains, Managing Director and CEO, Syngene International Limited, said, “Our Q2 performance was driven by underlying revenue growth from research
Union Health Minister J.P. Nadda has highlighted the remarkable transformation of India’s healthcare landscape, noting that the country has expanded from a single All India Institute of Medical Sciences (AIIMS) in New Delhi to 23 AIIMS across the nation, symbolizing a new era of accessible
India’s Molbio Diagnostics has been awarded the prestigious Kochon Prize 2024 for its groundbreaking portable molecular diagnostic platform, a transformative innovation that has significantly advanced the fight against infectious diseases globally. The Kochon Prize, instituted by the Stop TB Partnership and funded by the Kochon Foundation
Aster CMI Hospital has once again showcased its clinical excellence by successfully performing a complex surgical procedure to remove a massive 9 kg ovarian cyst from a 47-year-old woman. The surgery not only relieved the patient of a life-threatening condition but also preserved her hormonal
Dr Srivatsa Lokeshwaran, Lead Consultant and Head of Department - Interventional Pulmonology and Lung Transplant, Aster Whitefield Hospital A recent WHO study reveals that children are, on average, nine times more likely than adults to vape. Experts share how vaping has similar effects as traditional smoking. According
